Literature DB >> 27423462

qSOFA does not replace SIRS in the definition of sepsis.

Jean-Louis Vincent1, Greg S Martin2, Mitchell M Levy3.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27423462      PMCID: PMC4947518          DOI: 10.1186/s13054-016-1389-z

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.
The recently published consensus definitions for sepsis [1] have raised a lot of discussion and controversy. We had the privilege of being part of this consensus group and fully support the final definitions. We are pleased that a definition has been developed that closely reflects everyday clinical language, recognizing that sepsis is most simply described as a “bad infection” associated with some degree of organ dysfunction, as proposed earlier [2]. The article conveying the consensus definition [1] also emphasizes that sepsis is more often recognized from the associated organ dysfunction than from the more difficult to identify infection, so that sepsis can be defined as “life-threatening organ dysfunction caused by a dysregulated host response to an infection”. The proposition of the 1992 North American consensus document [3] that sepsis be defined by a combination of the systemic inflammatory response syndrome (SIRS) and the presence of an infection raised confusion, because the SIRS criteria (especially fever, tachycardia, and altered white blood cell count) are themselves typical features of infection [3]. As the majority of infected patients will therefore meet the SIRS criteria, they would also be considered to have sepsis by this 1992 definition. This approach to defining sepsis has resulted in a dramatic increase in the number of patients diagnosed with sepsis over the years [4]; however, these patients may have less severe disease so that reported parallel reductions in mortality rates [5] may be deceptive [6]. The recent “new” definitions are not so novel, more a return to the traditional use of the term to indicate patients with a substantial and deleterious response to an infection. We doubt that this will change further over time, exactly as the meaning of other words like pneumonia, peritonitis, or meningitis has not changed. We all agree on the fundamental importance of identifying sepsis early and of applying effective and complete treatment to minimize complications. However, the SIRS criteria were too sensitive and not sufficiently specific for this purpose. Rangel-Frausto et al. [7] reported that 68 % of patients admitted to three intensive care units (ICUs) and three general wards met the SIRS criteria; in 198 ICUs in 24 European countries, Sprung et al. [8] reported that 93 % of ICU patients had at least two SIRS criteria at some point during their ICU stay; and in a database of patients in 23 Australian and New Zealand ICUs, Dulhunty et al. [9] reported that 88.4 % of patients had at least two SIRS criteria on ICU admission. In a recent analysis of a large US database, Churpek et al. [10] reported that almost half of the 270,000 patients hospitalized on regular wards met the SIRS criteria at one time or another. Our consensus definition paper suggested the quick sequential organ failure assessment (qSOFA) as an effective way of raising suspicion of sepsis on the regular floor [1]. Evaluating all six components of the SOFA score can be time consuming, and some require laboratory measurements. By analyzing a large database of hospitalized patients, three clinical elements (hypotension, altered mentation, and tachypnea) were identified that could be used at the bedside to recognize those infected patients who are at risk of deteriorating or having a complicated course (death or ICU stay ≥ 3 days). The presence of two or more of these criteria can be used to prompt clinicians to further evaluate the patient for the presence of infection and/or organ dysfunction, to start or adapt treatment, and to consider transfer to an ICU. Importantly, this approach is designed to be an early warning system, and a patient with less than two qSOFA criteria may still raise concern. Clinical judgment should always supersede tools designed to help improve patient care, such as qSOFA. We would like to stress that, although SIRS was part of the definition of sepsis in 1992 [3], the qSOFA is not part of the new sepsis definitions. This important difference is illustrated in Fig. 1, with panel A showing that infection and sepsis (by the 1992 definition) are virtually the same—infection without SIRS can be found, but it is relatively rare. By contrast, panel B shows that sepsis (by the new SEPSIS-3 definition) represents only a minority of cases of infection. Moreover, panel B illustrates important aspects of the sepsis definition vis-à-vis infection and qSOFA. For example, sepsis can be present without a qSOFA score ≥ 2 because different forms of organ dysfunction may be present than are assessed using the qSOFA, such as hypoxemia, renal failure, coagulopathy, or hyperbilirubinemia. In addition, a patient may have a qSOFA ≥ 2 without infection; for example, in other acute conditions, such as hypovolemia, severe heart failure, or large pulmonary embolism. Further work remains to be done to determine the predictive validity of qSOFA in such patients. Finally, infected patients may have a qSOFA ≥ 2 and not be septic because the degree of hypotension, tachycardia, and/or altered mentation needed to fulfill qSOFA criteria is not the same as that needed to meet the SOFA organ dysfunction criteria necessary for a diagnosis of sepsis; the qSOFA criteria are thus clinically valuable but imperfect markers of sepsis. Nevertheless, in an analysis of a database of more than 74,000 patients, Seymour et al. [11] recently reported that 75 % of patients with suspected infection who had two or more qSOFA points also had at least two SOFA points.
Fig. 1

Schematic representation illustrating a the almost complete overlap of sepsis and infection when the SIRS criteria of the 1992 criteria [3] are used and b the differences between qSOFA and sepsis. qSOFA quick sequential organ failure assessment, SIRS systemic inflammatory response syndrome

Schematic representation illustrating a the almost complete overlap of sepsis and infection when the SIRS criteria of the 1992 criteria [3] are used and b the differences between qSOFA and sepsis. qSOFA quick sequential organ failure assessment, SIRS systemic inflammatory response syndrome We hope this editorial will clarify that the qSOFA is meant to be used to raise suspicion of sepsis and prompt further action—it is not a replacement for SIRS and is not part of the definition of sepsis.

Abbreviations

ICU, intensive care unit; qSOFA, quick sequential organ failure assessment; SIRS, systemic inflammatory response syndrome; SOFA, sequential organ failure assessment.
  11 in total

1.  Incidence and Prognostic Value of the Systemic Inflammatory Response Syndrome and Organ Dysfunctions in Ward Patients.

Authors:  Matthew M Churpek; Frank J Zadravecz; Christopher Winslow; Michael D Howell; Dana P Edelson
Journal:  Am J Respir Crit Care Med       Date:  2015-10-15       Impact factor: 21.405

2.  Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Christopher W Seymour; Vincent X Liu; Theodore J Iwashyna; Frank M Brunkhorst; Thomas D Rea; André Scherag; Gordon Rubenfeld; Jeremy M Kahn; Manu Shankar-Hari; Mervyn Singer; Clifford S Deutschman; Gabriel J Escobar; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

3.  Sepsis definitions: time for change.

Authors:  Jean-Louis Vincent; Steven M Opal; John C Marshall; Kevin J Tracey
Journal:  Lancet       Date:  2013-03-02       Impact factor: 79.321

4.  Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012.

Authors:  Kirsi-Maija Kaukonen; Michael Bailey; Satoshi Suzuki; David Pilcher; Rinaldo Bellomo
Journal:  JAMA       Date:  2014-04-02       Impact factor: 56.272

5.  The epidemiology of sepsis in the United States from 1979 through 2000.

Authors:  Greg S Martin; David M Mannino; Stephanie Eaton; Marc Moss
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

6.  Does severe non-infectious SIRS differ from severe sepsis? Results from a multi-centre Australian and New Zealand intensive care unit study.

Authors:  Joel M Dulhunty; Jeffrey Lipman; Simon Finfer
Journal:  Intensive Care Med       Date:  2008-05-27       Impact factor: 17.440

Review 7.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

8.  Regulatory mandates for sepsis care--reasons for caution.

Authors:  Chanu Rhee; Shruti Gohil; Michael Klompas
Journal:  N Engl J Med       Date:  2014-04-16       Impact factor: 91.245

9.  An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence In Acutely Ill Patients (SOAP) study.

Authors:  Charles L Sprung; Yasser Sakr; Jean-Louis Vincent; Jean-Roger Le Gall; Konrad Reinhart; V Marco Ranieri; Herwig Gerlach; Jonathan Fielden; C B Groba; Didier Payen
Journal:  Intensive Care Med       Date:  2006-02-15       Impact factor: 17.440

10.  The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study.

Authors:  M S Rangel-Frausto; D Pittet; M Costigan; T Hwang; C S Davis; R P Wenzel
Journal:  JAMA       Date:  1995-01-11       Impact factor: 56.272

View more
  41 in total

1.  Scoring systems for the characterization of sepsis and associated outcomes.

Authors:  Natalie McLymont; Guy W Glover
Journal:  Ann Transl Med       Date:  2016-12

2.  A Comparative Analysis of Sepsis Identification Methods in an Electronic Database.

Authors:  Alistair E W Johnson; Jerome Aboab; Jesse D Raffa; Tom J Pollard; Rodrigo O Deliberato; Leo A Celi; David J Stone
Journal:  Crit Care Med       Date:  2018-04       Impact factor: 7.598

3.  Using scores in septic patients.

Authors:  Anna Maria Rusconi; Daniele Coen
Journal:  Intern Emerg Med       Date:  2019-05-09       Impact factor: 3.397

4.  The challenge of early identification of the hospital patient at risk of septic complications.

Authors:  Jean-Louis Vincent
Journal:  Ann Transl Med       Date:  2017-02

5.  Systemic inflammatory response syndrome, sequential organ failure assessment, and quick sequential organ failure assessment: more pieces needed in the sepsis puzzle.

Authors:  Bin Du; Li Weng
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 6.  SIRS or qSOFA? Is that the question? Clinical and methodological observations from a meta-analysis and critical review on the prognostication of patients with suspected sepsis outside the ICU.

Authors:  Stefano Franchini; Luca Scarallo; Michele Carlucci; Luca Cabrini; Moreno Tresoldi
Journal:  Intern Emerg Med       Date:  2018-10-15       Impact factor: 3.397

7.  Clinical implications of the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Shannon M Fernando; Bram Rochwerg; Andrew J E Seely
Journal:  CMAJ       Date:  2018-09-10       Impact factor: 8.262

8.  A sirs-based automated alarm system for the diagnosis of sepsis after burn injury.

Authors:  J Gille; A Dietz; H Taha; A Sablotzki
Journal:  Ann Burns Fire Disasters       Date:  2017-09-30

Review 9.  New Consensus Definitions for Sepsis and Septic Shock: Implications for Treatment Strategies and Drug Development?

Authors:  Michael Berry; Brijesh V Patel; Stephen J Brett
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

10.  New-Onset Heart Failure and Mortality in Hospital Survivors of Sepsis-Related Left Ventricular Dysfunction.

Authors:  Saraschandra Vallabhajosyula; Jacob C Jentzer; Jeffrey B Geske; Mukesh Kumar; Ankit Sakhuja; Akhil Singhal; Joseph T Poterucha; Kianoush Kashani; Joseph G Murphy; Ognjen Gajic; Rahul Kashyap
Journal:  Shock       Date:  2018-02       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.